GSK shingles vaccine shows benefits across all age groups
April 28, 2015 at 06:38 AM EDT
LONDON, April 28 (Reuters) - An experimental shingles vaccine from GlaxoSmithKline is effective across all age groups, researchers said on Tuesday, boosting the prospects of a key product in the British drugmaker's development pipeline.